ONYIA JUDE (Chief Scientific Officer) sold 52.7% of their position (20.36K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $2.65M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/7/2025ACC: 0000914475-25-000149
Officer· Chief Scientific Officer
Since Nov 2021
-20.36K
Net shares
Net seller
$2.65M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20.36K acquired · 40.72K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20.36K
Price / share
$84.74
Trade value
$1.73M
% of position
111.3%
7/2/2025
18.29K→38.65K
Common Stock
Direct
Shares
−20.36K
Price / share
$130.13
Trade value
$2.65M
% of position
52.7%
7/2/2025
38.65K→18.29K
Total
Net shares
+0.00
Net value
-$924.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2025 | M · Option Exercise | +20.36K | $84.74 | $1.73M | 111.3% | 18.29K | 38.65K |
| Common Stock Direct | 7/2/2025 | S · Sale | −20.36K | $130.13 | $2.65M | 52.7% | 38.65K | 18.29K |
| Total | +0.00 | -$924.26K | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
20.36K shares
Shares
−20.36K
Strike price
84.74
Held after
95.09K
Exercisable
—
7/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock20.36K shares | 7/2/2025 | M · Option Exercise | −20.36K | 84.74 | — | 95.09K |